Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

Chief Operating Officer

Chief Financial Officer

Cheif Financial Officer

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÃƒÅ¡M Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-11	Premium	acquired	Premium	Premium	Premium	-
2024-04-11	Premium	acquired	Premium	Premium	Premium	-
2024-04-11	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-04-11	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-03-31	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-03-31	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-03-03	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-03-03	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-03-02	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-03-02	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-11-08	Premium	acquired	Premium	Premium	Premium	-
2022-06-09	Premium	acquired	Premium	Premium	Premium	-
2022-06-09	Premium	acquired	Premium	Premium	Premium	-
2022-06-09	Premium	acquired	Premium	Premium	Premium	-
2022-06-09	Premium	acquired	Premium	Premium	Premium	-
2022-03-03	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-03-03	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-01-26	Premium	bought	Premium	Premium	Premium	Chief Operating Officer
2021-11-19	Premium	bought	Premium	Premium	Premium	Chief Operating Officer
2021-11-18	Premium	bought	Premium	Premium	Premium	Chief Executive Officer

OPGN - OpGen Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for OPGN